NCT06382493View on ClinicalTrials.gov

Tegoprazan-containing Sequential for H. Pylori

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

December 12, 2024

Study Completion Date

December 12, 2024

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Tegoprazan-containing sequential H. pylori eradication therapy

tegoprazan was administered, instead propton-pump inhibitor, as acid blockade in H. pylori eradication sequential therapy

DRUG

Esomeprazole-containing sequential H. pylori eradication therapy

Esomeprazole was administered as acid blockade in H. pylori eradication sequential therapy (conventional acid blockade method for sequential eradication therapy)

Trial Locations (1)

463-707

RECRUITING

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER